Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data
TDM of PER could reduce the seizure frequency and is cost-effective for children with epilepsy. TDM of the PER in newly diagnosed epilepsy patients is strongly dominant because of its improvement in efficacy and reduction in cost.
Authors
- Jianhua Feng (ORCID: https://orcid.org/0000-0002-5849-407X)
- Shunan Chen
- Suhong Wang (ORCID: https://orcid.org/0000-0001-9526-9843)
- Lingyan Yu (ORCID: https://orcid.org/0000-0001-7828-139X)
- Yani Hu
- Haibin Dai (ORCID: https://orcid.org/0000-0002-5768-2714)
- Jie Chen (ORCID: https://orcid.org/0000-0002-8196-0454)
- Pu Miao (ORCID: https://orcid.org/0000-0001-5165-2613)
- Fengqian Mao
Institutions
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.3389/fphar.2025.1549069
- Citations
- 2
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Zhejiang Pharmaceutical Association